CAS: 40665-92-7; (E)-7-(2-((E)-4-(3-Chlorophenoxy)-3-Hydroxybut-1-En-1-yl)-3,5-Dihydroxycyclopentyl)Hept-5-Enoic Acid

该化合物是一种合成异丙二烯,主要用于兽医学中的合成异丙二烯,其有效润滑剂和子宫酸性能,其关键优点包括诱导牲畜,特别是牛和猪的静脉同步和分泌的高效性. 与异丙二烯受体有约束力的复合行为,导致润滑物回归并随后导致激素变化,从而便利受控繁殖周期. 氯丙烯醇因其在标准储存条件下迅速采取行动,作出可预测的反应和保持稳定而受到重视. 其精确的剂量和可靠的性能使得它成为生殖管理方案的首选,提高了农业环境中的畜牧肥力和作业效率.

结构式图片

欧盟法规

ECHA物质C&L通报REACH预注册

上下游产品

[3aα,4α(E),5β,6aα]-(+/-)-4-[4-(3-chlorophenoxy)-3-oxo-1-butenyl]-hexahydro-5-hydroxy-2H-cyclopenta[b]-furan-2-one 4-carboxybutyliden triphenylphosphorane sodium(+)-cloprostenol cloprostenol

合成工艺路线路线简述

    海关参考信息

    专利信息


    专利号:EP-1721894-A1
    优先权日:2005-05-13
    标题 :Process for the synthesis of prostaglandin derivatives
    发明人:LISI GIUSEPPE
    权利人:TECHNOPHARMA SA
    摘要:An alternative method for the synthesis of prostaglandin F analogues, in particular, analogues of PGF 2α and specifically for the synthesis of latano-prost, wherein the transformation of the lactone intermediate (5)n ninto the corresponding lactol (7)n nis carried out by treating the lactone intermediate (5) with a silane, preferably polymethylhydrosiloxane (PMHS), in the presence of a titanocene - and preferably titanocene fluoride. n The method enables considerable production economies with respect to the conventional reduction of lactone with diisobutylaluminum hydride (DIBAL-H).

    专利号:US-2015031898-A1
    优先权日:2012-03-09
    标题 :Process for preparation of prostaglandin f2 alpha analogues
    发明人:DAMS IWONA; KUTNER ANDRZEJ; CHODYNSKI MICHAL; KRUPA MALGORZATA; PIETRASZEK ANITA; ZEZULA MARTA; CMOCH PIOTR; KOSINSKA MONIKA
    权利人:INST FARMACEUTYCZNY
    摘要:A convergent synthesis of the prostaglandin F 2α analogues, travoprost and bimatoprost, was developed employing Julia-Lythgoe olefination of the structurally advanced phenylsulfone with an enantiomerically pure aldehyde ω-chain synthon. The novel convergent strategy allows the synthesis of a whole series of prostaglandin analogues of high purity from a common and structurally advanced prostaglandin intermediate.

    专利号:US-10100028-B2
    优先权日:2013-09-30
    标 题:Synthesis routes for prostaglandins and prostaglandin intermediates using metathesis
    发明人:YIANNIKOUROS GEORGE PETROS; KALARITIS PANOS; GAMAGE CHAMINDA PRIYAPUSHPA; AREFYEV DENIS VIKTOROVICH
    权利人:IRIX PHARMACEUTICALS INC; PATHEON API SERVICES INC
    摘要:Methods of synthesizing prostaglandins, prostaglandin analogs and their synthetic intermediates are described. The methods can comprise metal-catalyzed metathesis reactions. Also provided are synthetic intermediates that can be used in the synthesis of the prostaglandins and prostaglandin analogs.

    专利号:US-7772278-B2
    优先权日:1999-03-01
    标 题:Nitrosated and nitrosylated prostaglandins, compositions and methods of use
    发明人:GARVEY DAVID S; GASTON RICKY D; LETTS L GORDON; DE TEJADA INIGO SAENZ; TAM SANG WILLIAM; WORCEL MANUEL
    权利人:NITROMED INC
    摘要:The invention describes novel nitrosated and/or nitrosylated prostaglandins, and novel compositions comprising at least one nitrosated and/or nitrosylated prostaglandin, and, optionally, at least one compound that donates, transfers or releases nitric oxide, elevates endogenous levels of endothelium-derived relaxing factor, stimulates endogenous synthesis of nitric oxide or is a substrate for nitric oxide synthase, and/or at least one vasoactive agent. The invention also provides novel compositions comprising at least one prostaglandin and at least one S-nitrosothiol compound, and, optionally, at least one vasoactive agent. The prostaglandin is preferably a prostaglandin E 1 compound, more preferably alprostadil, and the S-nitrosothiol compound is preferably S-nitrosoglutathione. The invention also provides methods for treating or preventing sexual dysfunctions in males and females, for enhancing sexual responses in males and females, and for treating or preventing cerebrovascular disorders, cardiovascular disorders, benign prostatic hyperplasia (BPH), glaucoma, peptic ulcers or for inducing abortions.

    专利号:US-2004110228-A1
    优先权日:2002-04-01
    标 题:Combinatorial organic synthesis of unique biologically active compounds
    发明人:MCALPINE SHELLI R; TAYLOR RACHEL E; BOLLA MEGAN L; SEGALL ANCA M
    摘要:The invention provides a method for making a combinatorial library of cyclic compounds, such as Holliday junction-trapping compounds, comprising the steps of (a) obtaining a plurality of trimers according to the generic structure X 1- X 2- X 3 , wherein X 1 , X 2 and X 3 can be independently any naturally or nonnaturally occurring amino acids or peptidomimetics thereof; (b) optionally coupling a spacer S to the trimer at either end; (c) cyclizing two trimers or trimer-spacer conjugates in a head-to-tail orientation; thereby obtaining a combinatorial library of compounds, wherein the library does not include an unmodifed or naturally occurring Holliday Junction-trapping compounds. The invention additionally provides methods macrocyclic compounds that are synergimycin derivatives.

    专利号:US-8476471-B2
    优先权日:2009-07-13
    标 题 :Synthesis of prostanoids
    发明人:YIANNIKOUROS GEORGE PETROS; KALARITIS PANOS; GAMAGE CHAMINDA PRIYAPUSHPA; ABERNATHY STEPHANIE BOSSE
    权利人:YIANNIKOUROS GEORGE PETROS; KALARITIS PANOS; GAMAGE CHAMINDA PRIYAPUSHPA; ABERNATHY STEPHANIE BOSSE; IRIX PHARMACEUTICALS INC
    摘要:The presently disclosed subject matter provides a method of synthesizing prostaglandins and prostaglandin analogs comprising the ring closing metathesis of compounds of Formula (I). Also provided are novel compounds of Formula (I) and Formula (II). In addition to their use as synthetic intermediates in the presently disclosed methods, compounds of Formula (II) can be used as prostaglandin and/or prostaglandin analog prodrugs.
    台州市科瑞生物技术有限公司
    ⚠️ 未注册 · 未认证企业
    ⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
    数据来源于公开网络搜索,平台未作核实,请自行辨别。
    🏢敬请 企业认领
    🏬开设公司展台
    📢获取免费会员权益
    🎖️点亮专属注册企业标签
    📇展现公司完整信息 样本查看立即注册认领 →
    网址: http://www.pharm-intermediates.com
    企业联系电话:0576-88813233👤
    📞台州市科瑞生物技术有限公司 ⚠️参考联系方式
    联系人:金崇光
    电话:0576-88813233
    手机:13396860566
    传真:0576-88813233
    邮箱:sales@pharm-intermediates.com
    通信地址: 台州市开发大道东段288号
    邮编: 318000
    🆔 联系时候可告知是从"百琢研"平台获取的信息.
    ⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

    地址:台州市开发大道东段288号
    ⚠️ 未注册 · 未认证企业
    注册入口 备注: 📌 数据来源说明:本展台内容基于各搜索引擎等公开数据整理,仅作展示用途。请用户自行辨别
    ✉️ 若企业需抹除展台内容或有异议, 请通过页面底部联系方式告知我们,我们会尽快处理。
    第 1 / 1 页

    供应商参考报价(招募中)

    品牌试剂参考报价(招募中)

    📌 第三方产品分析报告

    ✅ COA系统入驻 | 共享模式

    主要参考文献


    1: Bourne GR, Moss SR, Phillips PJ, Shuker B. The disposition of the synthetic prostaglandin analogue cloprostenol ('Estrumate') in the rat and marmoset. Xenobiotica. 1979 Oct;9(10):623-31. doi: 10.1016/j.jaad.2014.10.012. Epub 2015 Jan 16. Review. doi: 10.1177/1060028014548569. Epub 2014 Sep 2. doi: 10.1186/1471-2415-14-32.
    7: Prévost S, Thai K, Schützenmeister N, Coulthard G, Erb W, Aggarwal VK. Synthesis of prostaglandin analogues, latanoprost and bimatoprost, using organocatalysis via a key bicyclic enal intermediate. Org Lett. 2015 Feb 6;17(3):504-7. doi: 10.1021/ol503520f. Epub 2015 Jan 12. doi: 10.1371/journal.pone.0095461. eCollection 2014.
    9: Bourne GR, Moss SR, Phillips PJ, Webster JT, White DF. Ion cluster techniques in drug metabolism: an example of the use of mixtures of the [12C]:[14C] isotopic forms of the synthetic prostaglandin cloprostenol ('Estrumate') to facilitate metabolite identification. Biomed Mass Spectrom. 1979 Aug;6(8):359-60. doi: 10.5301/ejo.5000506. Epub 2014 Jul 8. doi: 10.1097/IJG.0b013e31829e1b8b. doi: 10.1111/ceo.12163. Epub 2013 Aug 4. doi: 10.1097/IJG.0b013e3182867be3. doi: 10.1001/jama.2015.1348.

    合成参考文献


    摘要:Ammar DA, Kahook MY. Effects of benzalkonium chloride- or polyquad-preserved fixed combination glaucoma medications on human trabecular meshwork cells. Mol Vis. 2011;17():1806–13.
    参考文献:10.2165/11539460-000000000-00000
    摘要:Iskedjian M, Covert DW, Walker JH. Persistence with prostaglandin agonist use with and without adjunctive therapy for glaucoma patients: a Canadian population-based analysis. Patient. 2011;4(2):133–41. doi: 10.2165/11539460-000000000-00000.
    参考文献:10.1089/jop.2011.0003
    摘要:Altieri M, Ferrari E. Do Prostaglandin Analogs Affect Eyelid Position and Motility Journal of Ocular Pharmacology and Therapeutics. 2011 Oct;27(5):511–7. doi: 10.1089/jop.2011.0003.
    参考文献:10.1007/s12325-011-0043-z
    摘要:Scherzer M, Liehneova I, Muñoz Negrete FJ, Schnober D. Travoprost 0.004%/timolol 0.5% fixed combination in patients transitioning from fixed or unfixed bimatoprost 0.03%/timolol 0.5%. Advances in Therapy. 2011 Jul 15;28(8):661. doi: 10.1007/s12325-011-0043-z.
    📝 需求与反馈
    尽可能描述清楚需求与问题信息
    ×

    通知